Bank of America began coverage on shares of Xencor (NASDAQ:XNCR – Get Rating) in a research report report published on Friday, The Fly reports. The firm issued a buy rating and a $42.00 target price on the biopharmaceutical company’s stock. Several other research firms also recently weighed in on XNCR. SVB Leerink reiterated an outperform […]
Xencor, Inc. (NASDAQ:XNCR – Get Rating) – Investment analysts at Cantor Fitzgerald issued their FY2023 EPS estimates for Xencor in a research note issued to investors on Monday, May 15th. Cantor Fitzgerald analyst P. Stavropoulos expects that the biopharmaceutical company will post earnings of ($1.09) per share for the year. Cantor Fitzgerald currently has a […]
Xencor, Inc. (NASDAQ:XNCR – Get Rating) – Stock analysts at Cantor Fitzgerald issued their FY2023 EPS estimates for Xencor in a research report issued on Monday, May 15th. Cantor Fitzgerald analyst P. Stavropoulos anticipates that the biopharmaceutical company will post earnings of ($1.09) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating […]
/PRNewswire/ On May 12, the Vapouround Global Award, known as the "Oscars of the global vape industry", was held in Birmingham, UK. The "Industry Leader",.
Xencor (NASDAQ:XNCR – Get Rating)‘s stock had its “overweight” rating restated by equities researchers at Cantor Fitzgerald in a report released on Monday, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for Xencor’s FY2023 earnings at ($1.09) EPS. A number of other equities research analysts have also weighed in on XNCR. EF Hutton Acquisition Co. I […]